GILBERT S. OMENN - 09 Jun 2022 Form 4 Insider Report for Angion Biomedica Corp. (ELTX)

Role
Director
Signature
/s/ Jennifer J. Rhodes, as attorney-in fact for Gilbert S. Omenn
Issuer symbol
ELTX
Transactions as of
09 Jun 2022
Net transactions value
$0
Form type
4
Filing time
13 Jun 2022, 17:26:07 UTC
Previous filing
05 Jul 2022
Next filing
05 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELTX Common Stock Award $0 +15,000 $0.000000 15,000 09 Jun 2022 Common Stock 15,000 $1.73 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1.To vest on the earlier of the first anniversary of the date of grant or the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date.